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         Introduction
INTRODUCTION
Status Epilepticus (SE) is defined as a continuous convulsion lasting longer than 30min or the 
occurrence  of  serial  convulsions  between  which  there  is  no  return  of  consciousness  1.  SE  is  a 
condition  which  most  likely  will  not  terminate  rapidly  and  spontaneously;  and  requires  prompt 
intervention  2.  For all  practical  purpose,  any child  who continue to convulse when brought  to  the 
emergency room should be treated as a case of status epilepticus 2,3.
SE is the most common emergency in Pediatric Neurology. It may be classified as Generalized 
or Partial. Generalised Tonic Clonic Seizure ( GTCS ) is the predominate type in  SE 1.
Etiology:
There are three major subtypes of SE in children.
1) Prolonged febrile seizures; 2) Idiopathic SE, in which a seizure develops in the absence of an 
underlying Central Nervous System (CNS ) lesion or insult; and 3) Symptomatic SE, when seizure 
occurs as a result of an underlying neurologic disorder or a metabolic abnormality 1.
A febrile seizure lasting for more than 30 min, particularly in a child younger than 3 years of 
age, is the most common cause of SE. The Idiopathic group includes epileptic patients who have had 
sudden withdrawal of anticonvulsants (especially Benzodiazepines and Barbiturates) followed by SE. 
Epileptic children who are given anticonvulsants on an irregular basis or who are non compliant with 
drug treatment, are more likely to develop SE. SE may be the initial presentation of epilepsy. Sleep 
deprivation  and  intercurrent  infections  render  the  epileptic  patients  more  susceptible  to  SE.  The 
mortality and morbidity among patients with prolonged febrile seizures and idiopathic SE are low 1.
SE owing to other causes has a much higher mortality rate and the cause of death usually is 
directly attributable to the underlying etiology. Some of the causes for Symptomatic SE are Hypoxic 
Ischemic Encephalopathy (HIE ) sequelae,  encephalitis,  meningitis,  congenital  brain malformation, 
inborn errors of metabolism, electrolyte imbalance and brain tumours, particularly in the frontal lobe 1.
Management:
Early and effective treatment is essential to prevent prolonged seizures. Studies of prolonged 
seizures have established that the longer the duration of seizure before treatment ,the more difficult to 
stop it and  greater the risk for long term neurological sequelae 3.
Domicilary Treatment:
Prolonged seizures or clusters of seizures in children with known epilepsy can sometimes be 
managed at home with rectal Diazepam to prevent or abort SE 4. This is effective and can decrease 
the cost spent on the evaluation and further treatment of these patients  3. A rectal Diazepam gel is 
commercially available,  or  the intravenous preparation can be given rectally (0.4mg/kg) through a 
lubricated  syringe  4.  Only  a  single  prehospital  dose  of  rectal  Diazepam should  be  given  by  the 
caretakers 3. If the rectal dose fails to stop the seizures, the child should be bought to the emergency 
service immediately 4.
Hospital Treatment:
When a convulsing child presents to the emergency room, initial assessment should be rapid 
with directed history and physical examination. Confirm the diagnosis by observing the ictal behaviour 
and document the seizure duration. Note the nature of onset of seizure activity, history of fever or 
intercurrent illness, past history of seizures, medications and compliance, head injury, drug ingestion 
and toxin exposure.  Perform brief  general  and neurological  examination,  assess oxygenation and 
ventilation, note cyanosis, peripheral perfusion, pupil size, asymmetry on neurological examination, 
petechiae  or  purpura,   vesicles  and  deformity  or  soft  tissue  injury  of  head  2.  A  comprehensive 
examination should be undertaken once the seizures are controlled 1.
Initial treatment of patients begins with an assessment of the respiratory and cardiovascular 
systems.
1. The oral airway is secured and inspected for patency. The pulse, temperature, respiration and 
blood pressure are recorded.
2. Excessive oral  secretions  are removed by gentle  suction  and a  properly fitting face mask 
attached to oxygen is applied.
3. If patients do not respond to oxygen by mask, ventilation with bag and mask can be started. 
Consideration  should  be given to intubation  and assisted ventilation  1 during any stage in 
seizure management.
4. A  nasogastric  tube  is  placed  in  position  1 to  reduce  the  chances  for  regurgitation  and 
aspiration.
5. Venous  access  is  established  next.  Blood  is  withdrawn  for  measurement  of  glucose, 
electrolytes  and  anticonvulsant  level,  if  indicated.  Other  tests  (i.e.  a  toxic  screen)  are 
performed as indicated 4.
6. After  blood  is  withdrawn,  an  intravenous  infusion  of  saline  solution  is  started  4.  Shock,  if 
present, is corrected with Normal saline boluses.
7. Infuse Dextrose (2ml/kg of 25% solution) if hypoglycemia is confirmed or if Dextrostix is not 
available for immediate confirmation. Hyperglycemia has no adverse affect on outcome of SE 
2.
8. Hyperthermia  occurs  frequently  in  SE  and  is  primarily  due  to  motor  activity.  Given  the 
damaging  effects  of  fever  in  patients  with  central  nervous  injury,  hyperthermia  should  be 
treated promptly by passive cooling 3. 
Anticonvulsant Treatment:
In the convulsing patient, initial supportive, therapeutic and diagnostic measures need to be 
conducted simultaneously. The goal of anticonvulsant treatment is the rapid termination of clinical and 
electrical seizure activity by the prompt administration of appropriate drug in adequate doses with 
attention to the possibility of complicating apnea, hypoventilation and other metabolic abnormalities 3.
1. Drugs should always be administered intravenously (  I.V.  )  in the management of  SE; the 
intramuscular ( I.M. ) route is unreliable because some drugs are sequestrated by muscles 1. If 
I.V. access is not immediately available, intra-osseous access ( I.O. ) can be used safely in 
children 2.
2. It is essential to have resuscitation equipment at the bedside and the ability to intubate and 
ventilate the patient immediately if respiratory depression occurs 1.
3. Many anticonvulsant protocols and treatment guidelines are reported from various institutions 
and  groups.  Most  importantly,  every  institution  should  have  a  well  established  treatment 
protocol depending upon the local availability of   drugs 3. The timing, route and adequacy of 
dosages of drugs used are important.  Sufficient time must be allowed for the drugs to act 
before more of the same medication or another medication is used 2.
The management protocol commonly used is as follows:
  (PROCEED TO THE NEXT STEP, IF SEIZURE IS NOT CONTROLLED )
O minutes: A Benzodiazepine (Diazepam, Lorazepam or Midazolam) may be 
used intially, because these are effective for immediate control of
prolonged tonic clonic seizures in most children.
Diazepam is given I.V. in a dose of 0.1-0.3mg/kg at a rate no 
greater than 2mg/min. Respiratory depression and hypotension
can occur, especially if administered with a Barbiturate. The drug 
is effective but has a short half life and seizures may recur unless a
longer acting anticonvulsant is administered simultaneously 1.
Lorazepam is an equally effective short term anticonvulsant, with a
longer duration of action and decreased likelihood of producing 
hypotension and respiratory arrest. The recommended dose is 
0.05-0.1mg/kg I.V 1 ; a maximum of 4mg/dose is administered at rate                      
of2mg/min 2.                                                                                                 
Midazolam is given at a dose of 0.15-0.3mg/kg I.V. or I.M., if there is  no 
I.V / IO access 2.
10 minutes: Repeat Inj. Diazepam or Lorazepam in the same dose (2nd dose) 2
20 minutes: If seizure persist or even if the convulsive activity ceases after 
Diazepam or Lorazepam therapy, Phenytoin is given immediately 1.
Phenytoin  is administered at a loading dose of 20mg/kg I.V. slowly over 
20min (1mg/kg/min). The drug should be diluted only with normal
saline 2.
Fosphenytoin is a prodrug of Phenytoin, that can be used instead of 
Phenytoin by I.V. or I.M. route. The loading dose of 30mg/kg is to be 
administered I.V. over 10min (3mg/kg/min) 2
40 minutes: Inj. Phenytoin 10mg/kg over 10min (2nd dose)   
or 
Inj. Fosphenytoin 5mg/kg over 5min (2nd dose) is given 2.
Electrocardiography ( ECG ) is recommended during the loading phase 
to identify arrhythmias and bradycardia, a rare complication in children. 
Systemic hypotension may also complicate I.V. Phenytoin therapy
If the seizures do not recur, a maintanence dose of 3-9 mg/kg 
divided into two equal doses daily is begun 12-24 hrs later. Serum
Phenytoin levels should be monitored because the maintenance
dose varies considerably with age 1.     
60 minutes: Phenobarbitone is given in a loading dose of 15-20 mg/kg at the 
rate of 2mg/kg/min over 10 minutes in 1-2 ml/kg of NS or 5% 
Dextrose solution.
Phenobarbitone is a depressant drug and can lead to sedation 
and respiratory depression, especially when administered after
a Benzodiazepine. Thus during or following a loading dose,
assisted ventilation is usually required 2 .
With control of seizures, Phenobarbitone is given in a maintianence
dose of 3-5 mg/kg/24hrs divided into two equal doses 1.
If SE persists beyond this stage (i.e. longer than 60 min.) it is called      Refractory Status 
Epilepticus ( RSE ) and it  becomes more life threatening.
Constant I.V. infusion of either
Midazolam (0.2mg/kg bolus, 20-400 micro gm/kg/hr infusion)
                                                                  or
Propofol (1-2mg/kg, 2-10mg/kg/hr infusion) has been effective in 
managing seizures, during SE, unresponsive to other anticonvulsants 1. 
If seizures continue, serious consideration is given to induction of  Barbiturate Coma. In an 
intensive care unit,  the patient is placed on a ventilator and a continuous Electroencephalographic 
(  EEG )  monitor.  The initial  I.V.  loading dose of Thiopental  is 2 to 4mg/kg and is then titrated to 
achieve a burst suppression EEG pattern. Barbiturate coma is continued for atleast 48hrs, followed by 
cessation of thiopental until the serum Phenobarbital level falls to therapeutic range. Barbiturate coma 
requires careful monitoring because hypotension due to myocardial depression often requires presser 
therapy 1.
The other drugs that can be used for RSE are Diazepam infusion, Paraldehyde, Pentobarbital 
coma and ultimately General anesthesia with Halothane or Isoflurane and neuromuscular blockade 1,2. 
If the seizures are controlled at any of the above step, the child should be placed in recovery 
position, wherever applicable; the vital signs are closely monitored and the child is observed carefully 
for seizure recurrence  2.  Postictal confusion usually resolves over several hours and the failure to 
gradually improve must prompt a search for other causes such as hypoglycemia, CNS infection, CNS 
vascular event, toxic encephalopathy, and Non convulsive Status Epilepticus (NCSE). In particular 
NCSE can  present  with  subtle  behavioural  changes,  which  can  be  easily  discounted  unless  the 
clinician maintains a high index of suspicion. NCSE can be diagnosed by continuous EEG monitoring 
3.
Further Management :
           After the control  of  seizures and stabilization, identify precipitating factors, modify drug 
treatment and start maintainence therapy. Blood is obtained for complete blood count, urea, creatinine 
and lactate levels. Blood and urine may be obtained for metabolic studies and toxicological screening 
1. Arterial blood gas analysis is not routinely indicated2. It is wise to monitor oxygen saturation with an 
Oximeter. Examination of CSF is imperative, if meningitis or encephalitis is considered, unless there is 
contraindication  to  the  procedure  1.  In  this  case,  appropriate  antibiotics  should  be  administered, 
followed by imaging studies, before a lumbar puncture is attempted. CT scan is also required in  focal 
seizures or focal deficit, with history of trauma or bleeding disorder 2. 
Follow Up:
          A long term antiepileptic should be maintained ln children with progressive neurological disorder 
or with a history of recurrent seizures before the onset of SE. However in children with initial attack of 
Idiopathic SE, anticonvulsant is maintained arbitrarily for 3 months and then discontinued if the child 
remains asymptomatic 1.
Prognosis:
        The mortality rate of SE is approximately 5%. The greatest number of deaths occur in the 
symptomatic group, most of whom have a serious and life threatening CNS disorder. In the absence of 
a  progressive  neurologic  insult  or  metabolic  disorder,  the  morbidity  from  SE  is  low  1.  Thus  the 
prognosis of SE is related to the etiology and duration of seizures 2.
                Review 
Of 
  Literature
REVIEW OF LITERATURE
Seizures may have various appearances and of  different  causes.  Some are recurrent  and 
represent the various types of epilepsy, whereas others are single events Status Epilepticus ( SE ) 
represents  a  special  epilepsy  syndrome  and  it  is  a  true  neurologic  emergency  5  that  requires 
immediate and vigorous management;  and at  times poses a therapeutic  challenge to the treating 
physician. If not managed promptly, it may result in significant neuromorbidity and mortality 6.
SE is recognized as a distinct entity since 1824 5. However major advances appeared since the 
1980 Santa Monica International Conference on the treatment of SE, which included recognition of 
Subtle SE, Nonconvulsive status, new agents for SE and treatment of Drug Resistant SE 5.
Definition:
In the ‘Dictionary of Epilepsy’ , Gastaut (1973) defined SE as a “condition characterized by an 
epileptic seizure that is sufficiently prolonged or repeated at sufficiently brief intervals so as to produce 
an unvarying and enduring epileptic   condition”  7.  The main advantage of this definition is that it 
encompasses a variety of different seizure types 8. 
In  1981,  the  International  League  Against  Epilepsy  (ILAE)  defined  SE  as  a  seizure  that 
“persists for a sufficient length of time or is repeated frequently enough that recovery between attacks 
does not occur”. The lack of  specific duration of the seizures has made this definition difficult to use 9. 
More recent publications have defined SE as seizures that persist for 20 to 30 min, which is an 
estimate of the duration necessary to cause injury to CNS neurons  9. Thus SE is defined as single 
seizure or multiple episodes of seizures lasting more than 30 min without regaining consciousness in 
between 3. This precise definition of SE although useful for epidemiological analysis and evaluation of 
therapeutic interventions, does not address the urgency experienced by clinicians when confronted 
with a convulsing child,  irrespective of  how long the episode has lasted. It  therefore seems more 
appropriate to take a pragmatic view and consider SE as the severe and of a continuum encountered 
during the progressive evolution of an unrelenting seizure, which may culminate with potentially life 
threatening complications 3.
The current trend in the treatment of SE eliminates a specific duration for the diagnosis of SE 
and  emphasises  diagnostic  criteria  aimed at  improving  treatment  outcome.  This  trend  towards  a 
shorter seizure duration is supported by experimental evidence 9.
The operational definition of SE is “either continuous seizures lasting at least five minutes or 
two or more discrete seizures between which there is incomplete recovery of consciousness”. This 
definition differs from that of serial seizures, which are two or more seizures occurring over a relatively 
brief period (i.e. minutes to many hours), but with the patient regaining consciousness between the 
seizures 9. However the serial seizures requires the same vigorous management as SE 7.
Clinical Features:
When  first  seen,  patients  with  SE  are  unresponsive  and  usually  have  clinically  obvious 
seizures: such as tonic, clonic or tonic-clonic movements of the extremities. With time, however the 
clinical manifestations often become subtle, and the diagnosis requires careful observation. Patients 
may have only small amplitude twitching movements of the face, hands or feet, or nystagmoid jerking 
of the eyes. Some patients have no observable, repetitive motor activity, and the detection of ongoing 
seizures require Electroencephalography (EEG). Electrographic SE of this type may be more common 
in hospitalised, comatose patients than previously thought. Patients who have electrographic SE with 
little or no motor activity (including patients paralysed for airway management) are still at risk for CNS 
injury and require prompt treatment. Myoclonic SE, which is usually seen in patients after prolonged 
anoxia or other severe metabolic insults, consists of very brief, sudden movements of restricted parts 
of the body that may be triggered by external stimuli, such as mechanical ventilation 9.
Classification:
Most of the classification schemes divide SE into Convulsive and Non convulsive types. SE is 
then further defined utilizing the ILAE classification 8. 
I. Convulsive SE:
A. Generalised Convulsive SE
1. Tonic clonic SE
2. Tonic SE
3. Myoclonic SE
4. SE complicating Infantile spasms
B. Focal Convulsive SE
1. Partial elementary SE
2.   Partial SE with secondary generalisation 
 II. Non-convulsive SE
A. Generalised Non convulsive SE
1. Atonic, Akinetic, Myoclonic (Minor Motor) SE
2. Absence SE
B. Focal non convulsive SE
      Partial complex SE
For individual episodes of SE, an adequate description should include etiology,  physiologic 
expression of seizures activity and anatomic locus of  seizure discharge 8. .Generalised Convulsive SE 
(GCSE) is the most common and most dangerous type. GCSE can be further divided into overt and 
subtle types. Overt  GCSE is defined as recurrent convulsions without complete recovery between 
seizures. Subtle GCSE is defines as the stage of GCSE when the patient is in continuous coma but 
only subtle motor convulsions are seen 10. 
 Patients were classified as having one of these two types of SE according to the following 
operational  definitions.  Overt  GCSE  was  considered  present  when  there  were  two  or  more 
generalized  convulsions,  without  full  recovery  of  consciousness  between  seizures,  or  continuous 
convulsive activity for more than 5 min 9,10. Subtle GCSE was considered present when the patient had 
coma  and  ictal  discharges  on  the  EEG,  with  or  without  subtle  convulsive  movements  (rhythmic 
twitching of the arms, legs, trunk or facial muscles; tonic eye deviation; or nystagmoid eye jerking). If 
the investigator required an EEG to diagnose GCSE, the patient was considered to have subtle GCSE 
10 (Electroencephalographic SE) 9.
Although usually not considered in discussions of SE, some epileptic conditions that are unique 
to childhood have sufficient duration or recurrence rate to satisfy the formal definition; however, these 
epileptic syndromes are not usually approached diagnostically or therapeutically as SE 7.
Childhood conditions meeting the definitions of SE  7 
1. West syndrome (Infantile spasms with hypsarrythmia) 
2. Lennox  Gastaut syndrome
3. Landau  Kleffner syndrome
4. Pykno epilepsy
5. Epilepsia partialis continua (Rassmussen’s encephalitis) 
6. Continuous spike and wave during sleep.
7. Continuous occipital spike and wave during sleep.
SE can also be classified based on the age of occurrence  11   
1. SE confined to early childhood
- Neonatal SE
- SE in specific neonatal epilepsy syndromes
- Infantile spasms
2. SE confined to later childhood
- Febrile SE
- Status in childhood partial epilepsy syndromes
- SE in myoclonic astatic epilepsy
- Electrical SE during slow wave sleep                
-  Landau Kleffner syndrome                                                                                     
3. SE occurring in childhood and adult life
- Tonic Clonic SE
- Absence SE
- Epilepsia partialis continua
- SE in coma
- Specific forms of SE in mental retardation 
- Syndromes of myoclonic SE
- Simple partial SE
- Complex partial SE
4. SE confined to adult life
- de novo absence status and late onset
In 1980, Santa Monica International Symposium classified SE as follows 5:
1. Primary GCSE
- Tonic clonic status
- Myoclonic status
- Clonic-tonic-clonic status
2. Secondary GCSE
- Tonic clonic status with partial onset
- Tonic status
- Subtle GCSE
3. Simple partial status
- Partial motor status
- Unilateral status
- Epilepsia partialis continua
- Partial sensory status
- Partial status with vegetative, autonomic or affective symptoms
4. Non convulsive status:
- Absence status – typical or atypical
- Complex partial status
Most SE episodes in children appear to be generalised convulsive in character. Of those SE 
episodes  beginning  with  partial  seizures,  most  secondarily  generalise.  Careful  history  taking  and 
observation suggests that the majority (64% of adults and children) of all SE episode begin as partial 
seizures that generalize so that the final character is generalized 12.
Etiology: 
Status epilepticus may be the presentation of wide spectrum of disease processes 13:
1. Infective conditions:            Tuberculous Meningitis
Pyogenic Meningitis
Viral Encephalitis
2. Vascular conditions : Cortical vein thrombosis, 
    Cerebral artery thrombosis
                                                Vasculitis
3. Neurocutaneous
  syndromes : Neurofibromatosis
Tuberous Sclerosis
Sturge Weber syndrome
Incontinentia Pigmenti
4. Congenital malformations :  Absence of Corpus Callosum
Hydrocephalus
Porencephaly
Lissencephaly
 Schizencephaly
5. Matabolic conditions : Hypoglycemia
Hypocalcemia
Hypomagnesemia
Hyponatremia
Hypernatremia
Uremic encephalopathy
Reye’s syndrome
6. Congenital metabolic errors : Phenyl Ketonuria
Urea cycle disorders
Lactic acidosis
Menke’s kinky hair disease
7. Degenerative conditions : Generalised Gangliosidosis
Alper’s disease
Batten’s disease
8. Tumours : Intracranial space occupying lesions
9. Head trauma : Contusions and lacerations of brain
Subdural haematoma 13
10. Toxic encephalopathy : Lead  6,7                                                
Certain  etiologies  are  unique  to  the  pediatric  population,  including  those  responsible  for 
recurrent neonatal seizures such as traumatic subarachnoid hemorrhage, neonatal HIE and inborn 
errors of metabolism. Fever as the sole precipitating event of recurrent seizures and SE is also seen 
only in the young patients 7.  
For simplification, the variable etiologies of GCSE can be classified as follows 8:
1. Acute encephalopathies
Most common - Meningitis
Encephalitis
Dehydration
Electrolyte disorders
Others - Head trauma
Hypoxic or Anoxic injury 
Toxin ingestion
Hypoglycemia
Hypocalcemia
2. Chronic Encephalopathies:
Remote symptomatic brain injury
Cerebral palsy
Brain malformations
Neurocutaneous syndromes
Progressive CNS degenerative disease
3. Idiopathic (Cryptogenic) seizures:
Febrile
Afebrile
Seizures in the acute category are often difficult to control and are associated with a higher 
mortality  9. In contrast to adults, brain tumours and alcohol are seldom implicated in the etiology of 
acute SE in children 8. It has been observed that the classical symptoms and signs of acute bacterial 
meningitis may be absent in SE and a high index of suspicion for infection in the child with SE and 
fever is paramount. Systemic disorders like hypertension may occasionally present with SE 6.
In general, patients with SE due to chronic processes respond well to anticonvulsant treatment 
and they recover from the acute episode of seizure 9. With chronic encephalopathies, the lesions are 
widespread and do not have the frontal predominance reported in series of adults with SE 8. 
The most important cause for SE varies with the age of the child. Whereas febrile SE is the 
most common cause in children less than 5 years of age, trauma and infections are important in older 
children. Severe hypoxic encephalopathy and in born error of metabolism may present with SE in the 
newborn 6.
The important risk factors for SE are a history of epilepsy, younger age of patient,  genetic 
predisposition and acquired brain insult 6. Precipitating factors leading to SE can often be identified in 
children with chronic encephalopathies  8. The important precipitating factors include fever, irregular 
intake or sudden discontinuation of antiepileptic drugs, overdose of antiepileptic medications, sleep 
deprivation, fatigue, metabolic derangements, concomitant use of other medications (Theophylline, 
Amphetamine,  Isoniazid,  Phenothiazines),  psychotic  disturbances,  hyperventilation  and intermittent 
photic stimulation 6.
Pathophysiology:
The fundamental pathophysiology of SE involves a failure of the mechanisms that normally 
abort an isolated seizure. This failure can arise from abnormally persistent, excessive excitation or 
ineffective recruitment of inhibition. The relative contributions of these factors are poorly understood. 
The temporal  and spatial  determinations of  SE are also  relatively  unknown;  experimental  studies 
suggest that there is induction of reverberating seizure activity between, for example, hippocampal 
and  parahippocampal  structures  and  that  the  seizures  progress  through  a  sequence  of  distinct 
electrographic changes 9.
It is likely that numerous mechanisms are involved, depending on the underlying cause:
1. Excessive activation of excitatory amino acid receptors by Glutamate and Aspartate (excitatory 
amino acid neurotransmitters) may cause SE 9,13.
2. Decreased Gama Amino Butyric Acid (GABA) level may also precipitate convulsions 13. SE can 
be caused by Penicillin  and related compounds that  antagonise the effects of  GABA. The 
failure of inhibition may be due in some cases to a shift  in the functional properties of the 
GABA receptor that occurs as seizures become prolonged 9.
3. Repeated subconvulsive stimulation i.e. kindling may induce SE 13.
4. Abnormal  pathological  changes  in  brain  like  glioma,  hamartomas,  arterio  venous 
malformations, gliosis particularly in Amygdala precipitate SE 13.
5. Substantia nigra may be responsible for initiating convulsions 13. 
Pathogenesis:
SE lasting approximately 30 to 45 min can cause cerebral injury, especially in limbic structures 
such as the hippocampus and seizure activity itself is sufficient to damage the CNS. This damage is 
partly a consequence of Glutamate mediated excitotoxicity and does not appear to be due primarily to 
an  excessive  metabolic  demand  imposed  by  repetitive  neuronal  firing.  The  superimposition  of 
systemic stresses such as hyperthermia, hypoxia or hypotension exacerbates the degree of neuronal 
injury in animal models of SE, a finding consistent with the empirical observations in humans 9. 
In many encephalopathies, including the SE poor cerebral blood perfusion is the final common 
pathway. The decrease in local cerebral blood flow below a critical threshold, results in the following: 
energy  failure,  tissue  acidosis,  disturbed  ion  homeostasis  (characterized  by  enhanced  cellular 
Potassium efflux and Sodium and Calcium influx), membrane depolarization and cytotoxic edema. A 
massive release of the excitatory amino acid neurotransmitters, Glutamate and Aspartate, and the 
activation of Glutamate receptors [including N- methyl d-Aspartate ( NMDA ) receptors) have been 
ascribed a major pathophysiological significance. This triggers further membrane depolarization and 
additional  accumulation  of  free  cytosolic  Calcium ions  by cellular  influx,  release from intracellular 
compartments and disturbed extrusion mechanisms. The Calcium ion accumulation then seems to 
play a key role in propagation of the process eventually culminating in irreversible neuronal damage, 
in that it leads to an activation of series of neurotoxic events, such as lipid peroxidation, free radical 
generation, activation of proteolytic enzymes and pathological gene activation. In addition, microglial 
cells seem to have a significant role, in that they are important source of free radicals 14.
Pathology:
At  autopsy,  the  cerebral  hemispheres  are  congested  and  edematous  with  petechial  & 
microscopic  hemorrhages.  The  most  vulnerable  areas  in  brain  are  Hippocampus,  Amygdala, 
Cerebellum, Middle cortical layer and Thalamus 13. At the cellular level, ischemic cellular changes due 
to an increase in metabolic demand, depletion of glucose stores and oxygen supply are the earliest 
histologic  findings  6.  This  is  followed by neuronophagia,  microglial  and astrocyte proliferation  and 
neuronal loss 13
Phases of Status Epilepticus:
The physiological changes in SE are often divided into two phases (Phase 1 and Phase 2) if 
the convulsion occurs for about 30-60 min. These changes do not necessarily occur in all cases. The 
rate and extent of physiological changes are dependant on many other factors like.
1. Anatomical site of epileptic focus
2. Severity of the seizure
3. Underlying etiology and
4. the treatment employed
The phases of changes is useful in devising a rational plan for therapy 11,13.   
Phase I:
During this phase, cerebral metabolism is greatly increased because of seizure activity, but 
physiological  mechanisms  are  sufficient  to  meet  the  metabolic  demands,  and  cerebral  tissue  is 
protected from hypoxia or  metabolic damage. The major  physiological  changes are related to the 
greatly increased cerebral blood flow and metabolism, massive autonomic activity and cardiovascular 
changes 11. 
Phase 2:
During this  phase,  the greatly  increased cerebral  metabolic  demands cannot  be fully  met, 
resulting  in  hypoxia  and  altered  cerebral  and  systemic  metabolic  patterns.  Autonomic  changes 
persists and cardiorespiratory functions may progressively fail to maintain homeostasis. The tansition 
from phase 1 to 2 occurs after about 30-60 min of continuous seizures 11.
  The physiological changes in the two phases of SE can be tabulated as follows:
Features Phase 1
(Compensation)
Phase 2
(Decompensation)
Cerebral changes Increased blood flow
 
Increased metabolism
Energy requirements
       matched by supply of
       oxygen & glucose
      (increased glucose 
      and oxygen utilization)
Increased lactate
       concentration
Increased glucose
       concentration
Failure of cerebral auto
         regulation; thus cerebral
         blood flow becomes
         dependent on systemic 
         blood pressure 
Hypoxia
Hypoglycemia
Falling lactate concentration
Falling energy state
Rise in intracranial pressure and 
          cerebral edema
Systemic and 
metabolic 
       changes
Hyperglycemia
Lactic acidosis
Hypoglycemia
Hyponatremia
Hypokalemia / hyperkalemia
Metabolic & respiratory acidosis
Hepatic and renal dysfunction 
Consumptive coagulopathy, 
Multiorgan failure
Rhadomyolysis, Myoglobinuria
Leucocytosis
Autonomic and 
cardio vascular 
changes
Hypertension (initial) 
Increased cardiac output 
Systemic hypoxia
Increased central venous 
                       pressure 
Massive catecholamine 
                    release
Tachycardia
Cardiac dysrrhythmia
Salivation
Hyperpyrexia
Vomiting
Incontinence 
Falling blood pressure
Falling cardiac output
Respiratory and cardiac 
       impairment. (pulmonary 
      edema, pulmonary 
      embolism, 
      respiratory collapse, cardiac 
      failure, dysrrhythmia)
Hyperpyrexia
. 
Other laboratory abnormalities:
A number of laboratory abnormalities may be found during generalized convulsive SE.
1. A peripheral leukocytosis occur in approximately two thirds of episodes 8.
2. Acidosis is common, with an initial pH of less than 7.3 in 60-80% and a pH of less than 7.0 in 
12.5 – 33% 8. The lactic acidosis is due to glycolysis, tissue hypoxia, impaired respiration and 
catecholamine release 13.
3. There may be minimal elevations in CSF white blood cell count with no explanation other 
than SE. Woody et al found more than 5 WBCs in 5 of 20 CSF specimens obtained from 
children with SE who had no evidence of CNS infection. In a study by Dunn et al, 6 of 64 
children had elevated CSF white blood cells ranging from 8 to 25 WBC / mm3    8.
4. Hormonal changes seen in SE are increased levels of Prolactin, ACTH, glucagon, growth 
hormone, Insulin & Epinephrine 13.
5.   Rhabdomyolysis in SE is due to persistent convulsive movements and can lead    on  to 
myoglobulinuria 13.
6.  Myoglobulinuria, dehydration & shock can cause Acute renal tubular necrosis,        which 
occasionally may end up with fulminant renal failure 13.
Stages Of Generalised Tonic Clonic Status Epilepticus:
               It is convenient to divide the treatment of status into stages. This is in recognition of the 
fact that the risk of cerebral damage caused by seizure activity is slight in the first hour or two of 
status, and increases with duration of ongoing electrographic activity after this. Intially relatively 
simple treatment  is  given,  but  within two hours,  if  the  epileptic  activity is  not  under  control, 
general anesthesia is recommended 11.
1. Premonitory Stage :
                  In patients with established epilepsy, there is often a prodromal period before status 
develops in which there is a gradual increase ( over hours ) in the frequency of epileptic seizures. 
Parenteral drug treatment during this stage will usually terminate the seizures and prevent true status 
developing.  The  conventional  treatment  is  with  either  IV  or  Rectal  Diazepam.  Other  alternatives 
include IV Lorazepam or Midazolam by Buccal or IM route 11. 
2. Early  Status Epilepticus :
               This is the first  30 min of status. It  is  usual to initiate treatment with a fast acting 
Benzodiazepine, and Lorazepam is the drug of choice. In most episodes of status, initial treatment will 
be effective. Even if seizure cease, 24 hrs inpatient observation should follow. In persons without a 
previous history of epilepsy, chronic antiepileptic drug treatment should be introduced, and in those 
already on maintainence antiepileptic treatment, this should be reviewed 11.
3. Established Status Epilepticus :
              There are three alternative first line treatment options, but each has drawbacks and status at 
this  stage  carries  an  appreciable  morbidity.  These  are  subanesthetic  doses  of  Phenobarbitone, 
Phenytoin  or  Fosphenytoin.  Athree  are  given  by  IV  loading,  and  followed  by  repeated  oral 
( Phenobarbitone or Phenytoin ) or IV supplementation.
              Subanesthetic doses of Benzodiazepines should not be given at this stage, as they carry the 
risk of respiratory depression, hypotension and sudden collapse 11.
4. Refractory Status Epilepticus :
              In most patients, if seizures continue for 60 to 90 min inspite of the treatment outlined above,  
full anesthesia is required. The prognosis in status requiring anesthesia is much poorer, and there is a 
high risk  of mortality and morbidity. The drugs used are Barbiturates ( Thiopental ), Benzodiazepines ( 
Midazolam ) and Propofol.
               All the anesthetic drugs are given in doses sufficient to induce deep unconciousness; and 
therefore assisted respiration, intensive cardiovascular monitoring and full panoply of intensive care 
are essential. the depth of anesthesia should be that which abolishes all clinical and EEG epileptic 
activity ( often requiring sedation to the point of burst suppression on the EEG ), and cerebral electrical 
activity by necessity be visualized, either with a formal EEG or a cerebral function monitor 11.    
Management:
Three factors appear to be related to mortality and mobility of SE: 1) duration of seizures, 2) 
age and 3) etiology 12. Thus the only major variable of SE that can be altered with rapid and effective 
treatments is its duration 15. The longer the seizure lasts, the more difficult it will be to stop 12. Hence it 
is imperative that every possible effort be taken to cease the seizures as early as possible.
Prehospital treatment:
Retrospective  studies  in  adults  and children suggest  that  prehospital  therapy shortens the 
duration of SE and simplifies subsequent management in Emergency department 9.
Knudsen in 1979 found Diazepam rectal administration to be effective in the acute therapy of 
convulsions in children 7. This observation has revolutionized status epilepticus management. Hoppu 
and Santavuori (1981) used Diazepam rectal solution in treating known seizure disorder children with 
prolonged seizures at home. 67% of seizures were stopped in less than 15 min 7. However the rectal 
route is not always acceptable or convenient.
Although Lorazepam has also been administration rectally to treat seizures in children, studies 
of pharmacokinetics in adult volunteers indicated that peak concentrations attained are significantly 
lower and later than concentrations attained after the same dose given intravenously;  dose 2 to 4 
times higher than the I.V. dose, which are necessary to achieve early, effective serum concentrations, 
may pose the risk of prolonged toxicity 15.
Lorazepam is also used by the sublingual route for rapid effect. Yager and Seshia reported 
absorption of sublingual lorazepam within 20 seconds and subsequent control of serial seizures in 8 of 
10 children within 15 min 15.
A  clinical  study  in  San  Francisco,  United  States  of  America,  compared  the  use  of  I.V. 
Lorazapam and I.V. Diazepam in a prehospital setting by paramedics. The authors concluded that 
paramedics can administer Benzodiazepines in a safe and effective manner out of hospitals in adults, 
and I.V. Lorazepam was superior to Diazepam; a potential limitation is the need for refrigeration, which 
may limit its use outside the hospital 15l.
Midazolam is an imadazobenzodiazepine drug, which stands out in comparison with the other 
benzodiazepines  because  it  is  water  soluble  and  can  be  administered  intramuscularly.  Since  its 
introduction as an antiepileptic agent. Midazolam has been used in the prehospital setting for SE via 
intravenous, intramuscular, intra nasal, rectal and buccal routes 15.
I.M. Midzolam stops seizures within 5 to 10 min. I.V. access in the prehospital setting can be 
difficult  in  certain  patients  who  are  seizing  especially  children,  the  elderly  or  obese  patients. 
Intramuscular Midazolam treatment may be easier, safer, more predictable and effective treatment 
option than either Diazepam or Lorazepam treatment by the rectal or I.M. routes. Both Diazepam and 
Lorazepam by I.M. route has slower & erratic absorption and more local discomfort 15.
Scott et al were the first physicians to show that buccal / sublingual Midazolam culd be rapidly 
absorbed with a cerebral effect seen on EEG within 5 to 10 minutes. Buccal Midazolam appear to 
have some distinct advantage over rectal Diazepam 15.
O’Regan  et  al  demonstreated  decrease  in  epileptiform  activity  with  intranasal  Midazolam 
administration. However Wallace comments that children who have seizures when febrile, frequently 
have an upper respiratory tract infection. Nasal secretions can dilute the Midazolam solution and make 
it more difficult for the agent to have contact with the absorbing surface 15.
Per rectal  Sodium Valproate can be given as a retention enema in a dose of  20mg/kg in 
children with Refractory SE 15. This treatment option need further evaluation in the field of domicilary 
management of seizures.
Propofol is a rapidly acting drug with short duration of action. The first study of prehospital use 
of Propofol was from Helsinki in 1995 15.
For the initial treatment of SE in the prehospital setting, Midazolam has significant potential but 
has limited practical experience in the community. More aggressive options, including Propofol, will 
have to be reserved for communities in which emergency medical services are equipped to provide 
cardiopneumatic support and direct physician input. Unfortunately in many communities, more basic 
concerns such as delayed response time and limited funding need to be addressed before these 
changes can be considered 15.  
Hospital Treatment:
In the hospital,  therapy must address the immediate problem of
 1) Stopping the seizures.
2) Providing supportive measures (supplemental  oxygen) a clear airway an intravenous 
glucose source, etc)
3) Detecting and correcting any predisposing or precipitating factors.
4) Incorporating a drug with a long half life to prevent the recurrence of seizures once they 
have been arrested 12.
Supportive measures:
In  all  patients  presenting  in  status,  the  protection  of  cardio  respiratory  function  takes  first 
priority 
1) Hypoxia is much worse than appreciated and oxygen should always be administered 11.
2) Blood pressure, respiration and cardiac function are maintained to avoid hypoxic is chemic 
damage to the brain. Resuscitation equipments should be available 12.
3) Blood  samples  are  obtained  for  electrolyte,  glucose,  blood  urea  nitrogen,  calcium  and 
magnesium measurements and if  the patient  has been treated previously for  seizures,  for 
antiepileptic drug level determinations 12.
4) An intravenous line is inserted for the infusion of a glucose solution to maintain the blood sugar 
level at approximately 150mg/dl. Fluids should be limited initially to 1,000 to 1,200ml/m2    12
5) Increased intracranial pressure is treated if evident 12.
Terminating  a  seizure  may  be  difficult  in  the  presence  of  an  uncorrected  underlying 
derangement such as hypoxemia, hyperglycemia, electrolyte disturbances, hyperthermia, dehydration 
or hypotension 12. These conditions, hence, should be detected early and corrected immediately.
Drug Therapy:
Benzodiazepines are the drugs first to be used in SE. Naquet et al and Gastaut et al were the 
first to document the use of intravenous diazepam in the treatment of     SE 15  . Because of its short 
half  life  due  to  rapid  and  extensive  redistribution  to  peripheral  fat  stores  the  duration  of  clinical 
effectiveness with Diazepam is only 20 to 30 min  15.  Therefore, even if  seizures are arrested,  an 
antiepileptic drug with a longer duration of antiepileptic drug with a longer duration of action must be 
given 12, within 20 min 6.
Lorazepam has been compared with Diazepam in many clinical trials and is considered by 
many as the drug of choice for  SE  15,10.  It  has a different  volume of distribution of the free drug; 
therefore its clinical effectiveness can last for several     hours  15 (12-24 hours)  6. The frequency of 
endotracheal intubation during SE in children who received lorazepam was significantly lower (27%) 
compared  with  those  who  received  diazepam  (73%)  16.  If  seizures  continue  after   two  doses  of 
lorazepam, additional doses are unlikely to be successful. If no response is seen within 5-7 minutes, a 
second drug should be added 15.
Phenytoin  is  the  next  step  in  treatment  of  SE.  Fosphenytoin,  is  a  newer  addition.  It  is  a 
phosphate ester prodrug of Phenytoin that is highly water soluble and buffered to a pH of 8.6 to 9.0. 
On reaching the vascular compartment Fosphenytoin is rapidly conveted to Phenytoin by organ and 
brain Phosphatases. This produces a faster administration (150mg Phenytoin Equivalents / min) and 
attainment of free Phenytoin level of approximately 2mg/ml in adults. There is less adverse effects 
(such as hypotension, phlebitis and soft tissue injury from extravasations) compared with Phenytoin 15.
In accepted protocols of SE, if the patient continues convulse after Phenytoin administration, 
Phenobarbitone is attempted. At doses necessary in the treatment of SE, Phenobarbitone uniformly 
causes  some  degree  of  respiratory  depression  and  CNS  alterations.  In  combination  with 
Benzodiazepines,  hypotension  and  respiratory  depression  are  significant  concerns.  Studies  have 
found  that  if  there  is  no  response  to  Lorazepam,  a  second  conventional  agent  (Phenytoin  or 
Phenobarbitone) will only be successful in terminating SE in an additional 3 to 7% of cases. Thus with 
the  limited  yield  from a  third  agent  and  the  added  adverse  effects  of  prolonging  SE,  there  is  a 
tendency to skip the step of Phenobarbitone 15. Alternatively I.V. Sodium Valproate 20 to 30 mg/kg I.V. 
Over 5 to 10 min can be used 17. Valproate has the added advantage of avoiding the risk of additional 
adverse respiratory of hemodynomic changes in critically ill patients 18. However,  Treiman proposed 
directly proceeding to an agent usually reserved for the treatment of Refractory SE after failure of a 
first line agent, as the second and third arms of drug treatment were only successful in 9.3% of overt 
GCSE and 7.5% of subtle GCSE 15. In a study comparing the four different drugs for initial therapy of 
SE, it ever found that Lorazepam is more likely than Phenytoin to be successful when used as the 
initial  I.V  treatment  for  overt  GCSE.  Although  Lorazepam  was  no  more  efficacious  than 
Phenobarbitone or than Dizepam and Phenytoin, it is easier to use. The risk of adverse effects like 
hypotension,  respiratory  depression  or  cardiac  arrhythmia,  appears  similar  with  any  of  the  four 
regimens  if  drugs  are  administered  at  a  safe  rate  to  the  patient.  Any  of  the  four  treatments,  if 
successful,  can  protect  equally  well  against  recurrence  10.  The  results  of  the  study  suggest  that 
treatment with Lorazepam alone may be sufficient and may obviate the need for I.V. Phenytoin or 
Fosphenytoin loading,  when SE is caused by a rapidly reversible process  9  (  subtherapeutic AED 
concentration or metabolic derangements). However, Lorazepam followed by Phenytoin is currently 
the treatment preferred by many neurologist and epileptologist 9,19. 
Refractory SE:
The definition of Refractory SE varies in the literature and is based on failure of appropriate 
medical treatment and the duration of SE. Patients are considered in Refractory SE when they have 
not responded to sequential treatment with a Benzodiazepine, Phenytoin and Phenobarbital (or) when 
the seizures continue for 60 to 90 minutes after the initiation of therapy . Aggressive intervention with 
anesthetic drugs is indicated and requires intensive care support and EEG monitoring 15.
Pentobarbital is a potent antiseizure drug with the most experience for short acting Barbiturates 
and is a standard choice for Refractory SE. The major adverse effect is severe hypotension requiring 
presser therapy 15.
Thiopental  is  the  most  rapidly  acting  Barbiturate  that  forms  Pentobarbital  as  an  active 
metabolite in the body.  It  is  used in treatment of  Refractory SE in some countries due to lack of 
Pentobarbital 15. 
Propofol  is  a  non  Barbiturate  anesthetic  agent  that  shows  efficacy in  the  management  of 
Refractory  SE.  Propofol  is  more  likely  to  provide  rapid  seizure  control  and  less  likely  to  cause 
tachyphylaxis,  at  a  lower  cost  when  compared  with  Midazolam.  Propofol  is  available  as  a  lipid 
emulsion and the high lipid content should be taken into account when determining fat and caloric 
intake. The lipid emulsion serves as a culture medium for bacteria, raising concerns about infection, 
but this risk is new reduced with the addition of EDTA as a preservative 15. However, serious doubts 
are  being  raised  on  the  safety  of  Propofol  in  treatment  of  RSE.  Several  case  reports  show an 
increased  risk  of  mortality  following  Propofol  therapy.  Midazolam  is  currently  widely  used  for 
Refractory SE therapy. Trachyphylaxis occurs in some patients within 24-48 hrs and the dose may 
need to be increased several folds to maintain seizure control 15.
Other drugs used in RSE  include Lidocaine, Clonazepam, Chlormethiazole 9, Valproic Acid in 
repeated boluses 18 or as continuous I.V. infusion 2 may be useful in RSE. Small children may be given 
mega doses of multivitamin, especially B1, B2, B12 and Biotin. Pyridoxin dependant seizures are not 
uncommon in infants 6. 
Failure To Respond To Emergency Treatment 11:
In the great majority of the cases, the above measures will control the seizures and the status 
will resolve. If drug treatment fails, there are often complicating factors.
The common reasons for treatment failure are:
1. Inadequate drug treatment :
Insufficient dosage of drug
Failure to initiate or continue maintainence antiepileptic drug therapy, 
resulting in recrudescence of seizures.
2. Additional medical factors :
Medical complications can exacerbate the seizures
Failure to treat ( or identify ) the underlying cause can result in intractable 
status ( e.g. cerebral infection ).
1. Misdiagnosis of Pseudostatus as a true epileptic status.
Complications  11  : 
Complications encountered in SE often need emergency treatment in their own right. Failure to 
do so can perpetuate the status and worsen outcome. 
             The medical complications in SE are as follows :
1, Cerebral : 
Hypoxic / Metabolic cerebral damage
Seizure induced cerebral damage
Cerebral edema and raised intracranial pressure
Cerebral venous thrombosis
Cerebral hemorrhage and infarction
2. Cardio-Respiratory and Autonomic :
Hypotension
Hypertension
Cardiac failure, tachy and brady dysrrhythmia, cardiac arrest, cardiogenic shock
Respiratory failure
Disturbances of respiratory rate and rhythm, apnea
Pulmonary edema, hypertension, embolism, pneumonia, aspiration
Hyperpyrexia
Sweating, hypersecretion, tracheobronchial obstruction
Peripheral ischemia
3. Metabolic and Ischemic :
Dehydration
Electrolyte disturbance ( especially hyponatremia, hyperkalemia )
Acute renal failure ( especially acute tubular necrosis )
Acute hepatic failure
Acute pancreatitis 
4. Others :
Disseminated intravascular coagulopathy
Multi organ failure
Rhabdomyolysis
Fractures
Infection ( especially pulmonary, skin, urinary )
Thrombophlebitis, dermal injury
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AIM OF THE STUDY
1. To study the clinical and epidemiological features of children with Generalized 
Convulsive Status Epilepticus.
2. To find out the complications and outcome in children with Generalized 
Convulsive Status Epilepticus.
3. To identify the risk factors for adverse outcome in Childhood Status Epilepticus.
    Materials 
And 
Methods
MATERIALS AND METHODS
Study Centre:
The study was conducted in the Emergency Room and the Intensive Care Unit of the Institute 
of Child Health and Research Centre, Government Rajaji Hospital, Madurai.
Study Period:
The Study was carried out from October 2005 to September 2006, a duration of one year.
Study Design:
It is a Prospective Descriptive Study.
Case definitions:
1. Status Epilepticus is defined as a continuous convulsion lasting longer than 30min or the 
occurrence of serial convulsions between which there is no return of consciousness.
2. The operational definition for convulsive Status Epilepticus includes:
a) more than 5 minutes of continuous seizures.
b) two or more discrete seizures between which there is incomplete recovery  of 
consciousness. 
3. Generalized convulsive status Epilepticus (GCSE) can be overt or subtle. 
Overt GCSE is defined as easily visible generalized convulsion.
Subtle GCSE is indicated by coma and ictal discharges on EEG, with or without  subtle 
convulsive movements such as rhythmic twitching of the arms,  legs,  trunk,  facial  muscles; 
tonic eye deviation; or nystagmoid eye jerking.
4. Patients are considered to be in Refractory Status Epilepticus (RSE) when seizures have 
lasted longer than 60 min even after they had sequential treatment with a Benzodiazepine, 
Phenytoin and Phenobarbitone.
Inclusion Criteria:
1. Children  with  Generalised  Convulsive  Status  Epilepticus  (GCSE)  who  were  brought  to 
Emergency room or who developed Status Epilepticus during hospitalization, were included in 
the study.
2. Age group selected was between 1 month and 12 years.
Exclusion Criteria:
1. All neonates were excluded from this study 
2. Children with focal or non convulsive status epilepticus were not included
Methodology:
A protocol for the management of children with Generalised Convulsive Status Epilepticus was 
developed under the guidance of Prof.Dr.D.Meikandan, Neurologist and Professor of Pediatrics of our 
institute. The designed study was approved by the Ethical Committee of our hospital.
All children with Generalized Convulsive Status Epilepticus were enrolled in the study as per 
the criteria specified. Consent for the study was obtained from the parents or the available attenders of 
the child. Following a brief history and rapid evaluation, the children were resuscitated and managed 
as  per  the  designed  protocol.  Blood  samples  for  the  biochemical  estimation  of  glucose,  urea, 
creatinine and bicarbonate were collected, as soon as an intravenous access was first established for 
management.  Supportive therapy, such as inotropes and mechanical ventilation were provided, as 
and when required.
Detailed history and thorough physical examination were completed once the seizures were 
controlled. Other investigations ( Lumbar puncture, EEG and CT-brain) were undertaken, as soon as 
the child’s clinical status was stable. Additional investigations were done, as and when warranted by 
the child’s clinical condition. Specific treatment such as antibiotics or antiviral agents was initiated, as 
early as possible based on the clinical suspicion and / or laboratory evaluation. All children were then 
followed up till their discharge from hospital or death.
The clinical response of the child to treatment, complications that developed during the course 
of hospitalization and the ultimate outcome of the illness were studied and documented in a printed 
proforma. Finally, all the data were collected, consolidated, analysed and interpreted statistically.    
Results 
And 
Analysis 
RESULTS AND ANALYSIS
Over  a  period  of  one  year  118  children  with  Status  Epilepticus  (SE)  were  treated  in  our 
Institute. Of this 68 cases were boys and 50 were girls. Thus the Male to Female ratio in the study 
population was 1.36:1 These children ranged in their age from 31 days to 12 years. The mean age at 
the time of presentation was 3.73 years (+3.19 yrs) (Table1) among males and 3.04 years (+2.49 yrs) 
among  females.  Three  fourth  of  the  total  cases  were  younger  than  4  years  of  age  and  infants 
constituted about 35% of the total cases (Table2). All children were from Grade 3& Grade 4 Socio 
Economic status as per modified Kuppusamy Scale20.
93.2% of children started convulsing elsewhere outside the hospital and were admitted in the 
Emergency Department with SE. Rest of the children (6.78%) developed seizures during the course of 
hospitalization, for some other ailment. Of the children who started convulsing prior to hospitalization, 
31.82% had  received  some  form  of  treatment  elsewhere  and  then  referred  to  our  Institution  for 
specialized care. In this prehospital treatment group, 57.14% had no details of the treatment received 
by them and 14.29% were given Diazepam by Intramuscular route, which is of no use in SE (Table 
1).The significant observation is that in about 75% of these children, the physicians have preferred the 
I.M.route for drug administration. 
The mean total seizure duration in the study group was 4 hours 52 minutes, which includes the 
one hour of mean treatment duration in the hospital (Table 3).
Generalized Tonic Clonic seizure was the most common seizure type. 25.42% of children had focal 
onset with secondary generalization, whereas 51.69% had generalized seizures from the begining. All 
other children had Myoclonic seizures (Table1). Subtle seizure activity was observed among 8% of 
children with GTCS. 
Table :1 SALIENT FEATURES OF THE STUDY POPULATION
S.No
.
Features Results
1. Total no. of cases 118
2. Total no. of Males 68
Total no. of Females 50
Male : Females 1.36 : 1
3. Age range 31 days to 12 years
4. Mean age at presentation
Males 3.73 yrs (+ 3.19 yrs)
Females 3.04 yrs (+ 2.49 yrs)
5. Prehospital Treatment received 35 ( 31.82% )
        Inj. Fosphenytoin I.M 1
        Inj. Diazepam I.V. 2
        Inj. Phenytoin I.V. 2
        Inj. Phenobarbitone I.V 3
          Drugs as per Protocol 1
        Rectal Diazepam 1
        Inj. Diazepam I.M                     5      (14.29%)
        I.M. Injections (Details not known)                   20      (57.14%)
6. Seizure onset 
        Prior Hospitalisation 110 (93.2%)
        In Hospital 8 (6.78%)
28.57%
7. Seizure type 
        GTCS – primary 51.69%
        GTCS - secondary 25.42%
        Myoclonic 22.88%
8. Seizure pattern 
         Continuous 55%
         Intermittent without regaining  
                         consciousness
45%
9. Refractory Status Epilepticus 22.03%
10. Interesting cases 
      Cerebral Palsy with Acute CNS  
        infection             
1
      Downs Syndrome with Acute CNS   
        Infection
1
      Seizure disorder with  Neem oil   
       Encephalopathy
2
      Cerebral palsy with Neem oil 
       Encephalopathy
1
      Arrested Hydrocephalus  1
11. Mean duration of hospitalization 6.3 days
12. Outcome 
      Survived 73(61.86%)
      Expired 45(38.14%)
13. Overall mortality rate 38.14%
14. Sequelae among Survivors 3 (4.1%)
       Right Hemiparesis 1
       HIE 2
 Table :2 AGE GROUP AND FINAL OUTCOME
Age group
 
Survived Expired Grand total Age specific 
Mortality Rate 
(per 100)
1mon - 1yr 21 21 (46.67%) 42 (35.59%) 50
1 – 2yrs 16 7 (15.56%) 23 (19.49%) 30.43
2 – 3 yrs 8 7 (15.56%) 15 (12.71%) 46.67
3 – 4yrs 8 1 (2.22%) 9 (7.63%) 11.11
4 – 8yrs 15 9 (20%) 24 (20.34%) 37.5
8 – 12 yrs 5 - 5 (4.24%) -
Total 73 45 (100%) 118 (100%)
Table :3  SEIZURE DURATION AND OUTCOME
Mean Seizure duration Survived Expired Mean Total 
duration
Prior hospitalization 3hrs 0 min 5 hr 26min 3hr 59min
In hospital 1 hr. 1hr 23min. 1 hr 08min.
Total duration 3 hr 56min. 6hr 20min 4hr 52min
Chart – 1
ETIOLOGY AND AGE GROUP DISTRIBUTION
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55% of  the  children  were  convulsing  continuously,  whereas  rest  of  them had  intermittent 
seizures without regaining normal level of consciousness in between (Table1). 
As  a  whole,  Seizure  Disorder  was  the  commonest  cause  for  SE  (42.37%)  in  the  study 
population. This was followed by Acute CNS Infection (26.27%) and Toxic encephalopathy (22.88%). 
Toxic  encephalopathy  (n=27)  includes  25  cases  due  to  Neem  oil,  one  case  of  Carbamazepine 
overdose and one due to herbal medicine(sangu ilai). However in infants Toxic encephalopathy was 
the dominant cause (38.1%) and Acute CNS Infection (26.19%) was the next common cause. Seizure 
disorder as a causative factor increases with advancing age of the child and more than 60% of the 
cases above 4 years of age were due to seizure disorder. Septicemia occurred only in infants and one 
child with Hypertensive encephalopathy due to Acute glomerulo nephritis was 12 years old (Table 4) 
Table 4:AGE GROUP AND ETIOLOGICAL DISTRIBUTION
Age 
gro
up
Acu
te 
CN
S 
infe
ctio
n 
(31)
Seizure 
disorder
(50)
Toxic 
enephalo 
pathy
(27)
Febrile 
SE
(5)
Septicemia
(4)
HT 
encephalo
Pathy
(1)
Total
1m
on 
-1yr
11
(26.
19%
)
9
(21.43%)
16
(38.10%)
2
(4.76%)
4
(9.52%)
- 42
1 – 
2 
yrs
6
(26.
09%
)
8
(34.78%)
7
(30.43%)
2
(8.70%)
- - 23
2 – 
3 
yrs
7
(46.
67%
)
7
(46.67%)
1
(6.67%)
- - - 15
3 – 
4 
yrs
0 7
(77.78%)
2
(22.22%
)
- - - 9
4 – 
8 
yrs
6
(25
%)
16
(66.67%)
1
(4.17%)
1
(4.17%)
- - 24
8 – 
12 
yrs
1
(20
%)
3
((60%)
- - - 1
(20%)
5
Tota
l
31(2
6.27
%)
50(42.37%
)
27(22.88%) 5(4.24%
)
4(3.39%) 1(0.08%) 118(100%)
One  fourth  of  the  cases  had  features  of  intercurrent  illnessess  like  respiratory  or 
gastrointestinal infections with fever, preceding the onset of SE. Such an observation was prominent 
in children with Acute CNS infection (61.29%) and Febrile SE (60%). All infants with septicemia were 
ill before they developed SE (Table 5) 
Table: 5: PRECEDING ILLNESS IN CHILDREN WITH STATUS EPILEPTICUS
Acute CNS 
infection
Seizure 
disorder
Toxic encepha 
lopathy
Septicemia Total
Fever 7 - - 2 9
Fever + URI 8 3 3 1 15
Fever + AGE 3 - - - 3
Fever + AGE 
+ URI
1 1 - - 2
Fever + UTI - - - 1 1
AGE- Acute gastro enteritis; URI- Upper respiratory infection; UTI- Urinary tract infection 
About 20% of children with SE responded to the first drug Lorazepam   and another 31.36% to 
the  next  drug,  Phenytoin.  Phenobarbitone was effective  in  terminating  the seizures  in  27.12% of 
cases. Thus only about 22% of the seizures were not responding to the first three drugs and entered 
the Refractory Phase.  However all  refractory Status Epilepticus were controlled with progressively 
increasing dose of Midazolam infusion (Table 6) 
Table: 6
ETIOLOGICAL DISTRIBUTION OF RESPONSE TO DRUG THERAPY AS PER PROTOCOL
Drugs Acute CNS 
infection (31)
Seizure 
disorder (50)
Toxic 
encephalopathy 
(27)
Febrile 
status 
epilepticus 
(5)
Septicemia
(4)
Hypertensive 
encephalopathy 
(1)
S E T S E T S E T S E T S E T S E
L1 3 - 3 
(9.68)
7 - 7 
(14)
2 - 2 
(7.41)
- - - - - -
L2 2 - 2 
(6.45)
4 2 6 
(12)
- 1 1 
(3.7)
- - 1 1 
(25)
1
PHT1 1 7 8 
(25.81)
11 - 11 
(22)
3 - 3 
(11.11)
2 2 
(40)
- - -
PHT2 2 3 5 
(16.13)
5 1 6 
(12)
- 1 1 
(3.7)
1 1 
(20)
- - -
PHB 3 2 5 
(16.13
12 2 14 
(28)
6 3 9 
(33.33)
2 2 
(40)
2 2 
(50)
-
Mid1 3 - 3 
(9.68)
2 3 5 
(10)
- 5 5 
(18.52)
- - 1 1 
(25)
-
Mid2 - - - 1 - 1 
(2)
- 5 5 
(18.52)
- - - - -
Mid3 - 4 4 
(12.9)
- - - - - - - - - - -
Mid6 - 1 1 - - - - - - - - - - -
(3.23)
Mid12 - - - - - - - 1 1 
(3.7)
1 - - - -
Total 14 17 31 42 8 50 11 16 27 5 5 4 4 1
            L- Lorazepam; PHT- Phenytoin; PHB- Phenobarbitone; Mid- Midazolam; S- Survived; E-
Expired; T- Total
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Of  the  118  cases  enrolled  in  the  study,  73(61.86%)  children  survived  and  45  (38.14%) 
succumbed to their illness. These patients remained hospitalized for a mean time period of 6.3 days. 
4% of the survivors left the hospital with sequelae. The overall   mortality rate among children with SE 
was 38.14.per 100 (Table 1). The various factors that influenced the morbidity and mortality following 
SE were selected and analysed statistically.
35% of the boys and 42% of the girls treated for SE expired. But this gender difference was 
statistically insignificant (p Value = 0.5828) (Table7). 
Table 7: Gender Distribution and Final Outcome
Gender Survived Expired Total
Male 44 24 (35.29%) 68 (100%)
Female 29 21 (42%) 50 (100%)
Total 73 45 118
p value = 0.5828
The mortality associated with SE was greatest (80%) in children younger than 4 years of age. 
This  age  difference  was  more  marked  in  infants  who  accounted  for  35.59%  of  total  cases  but 
contributed to 46.67% of total deaths. The age specific mortality rate was highest in infancy with 50 
deaths per 100 infants treated (Table 2). 
The mean total duration of seizure among the survivors (3 hr 56 min) was much lower than 
those who died (6 hrs 20 min). This is also true in the prehospital setting and following hospitalization, 
with survivors having shorter seizure duration. The mean seizure duration after initiating treatment was 
in the Refractory range (1 hrs 23 min) among the expired children (Table 3) 
About 38% of children   have expired both in the out-of-hospital onset group and the in-hospital 
onset group (Table 8). 
Table 8: PLACE OF SEIZURE ONSET AND OUTCOME
Seizure onset Survived Expired Total
Out of hospital 68 
(61.82%)
42
(38.18%)
110 
In hospital 5
(62.5%)
3
(37.5%)
8 
Total 73 45 118
But in the former group about 57.14% of children who have received some treatment outside 
had expired. This is statistically significant (p value = 0.0097) when compared with those who visited 
our Emergency Department straight from their home, without being treated elsewhere (Table 9). 
Table: 9
PREHOSPITAL TREATMENT AND OUTCOME IN CHILDREN WITH SEIZURE ONSET PRIOR 
HOSPITALISATION
Prehospital treatment No Prehospital treatment
Survived Expired Total Survived Expired Total
Total 
No.
Seizure onset 
prior 
hospitalization
15
(42.86%)
20
(57.14%)
35
(31.82%)
53
(70.67%)
22
(29.33%)
75
(68.18%)
110
p Value     =    0.0097 (significant)
However, careful analysis reveals that man children who died after prehospital treatment has 
Acute  CNS  infection  or  Toxic  Encephalopathy,  the  two  etiologies  with  greater  mortality  rate,  as 
discussed  later.  Thus  the  unyielding  nature  of  the  seizures  due  to  the  underlying  etiology,  with 
increased seizure duration may be the reason for this paradoxical observation.
Chart – 3
ETIOLOGICAL GROUP AND SURVIVAL
0
10
20
30
40
50
Acute CNS
Infection
Seizure
Disorder
Toxic
encephalopathy
Febrile Status
Epilepticus
Septicemia Hypertensive
encephalopathy
Survived Expired
Acute  CNS  infection  was  the  major  contributor  to  mortality  (37.73%)  followed  in  close 
succession by Toxic Encephalopathy (35.56%). All children with Septicemia expired and none with 
Febrile  SE  or  Hypertensive  encephalopathy.  Toxic  encephalopathy,  next  to  Septicemia,  has  the 
highest specific mortality rate with 59.26 death per 100 and all these were due to Neem Oil ingestion 
(Table 10). 
Table 10: ETIOLOGICAL GROUP AND FINAL OUTCOME
S.No. Disease Survived Expired Total No. 
of case
Disease specific 
mortality rate 
(per 100)
1. Acute CNS 
infection
14 17 
(37.78%)
31 
(26.27%)
54.84
2. Seizure disorder 42 8 
(17.78%)
50 
(42.37%)
16.0
3. Toxic 
encephalopathy
11 16 
(35.56%)
27 
(22.88%)
59.26
4. Febrile status 
epilepticus
5 - 5 
(4.24%)
-
5. Septicemia - 4 
(8.89%)
4 
(3.39%)
100
6. Hypertensive 
encephalopathy
1 - 1 
(0.08%)
-
Total 73 45 118 
(100%)
Children who survived of Seizure disorder and Toxic encephalopathy had a shorter seizure 
duration and responded earlier to the drug therapy than those who expired of the same cause. Similar 
observation was conspicuous by its absence in children with CNS infection (Table 11). 
Table 11: Etiological Distribution of Seizure Characteristics
Features Acute CNS 
Infection
Seizure 
disorder
Toxic 
Enceptalopathy
Febrile 
status 
epilepticus
Septicemia Hypertensiv
e encepha-
lopathy
S E S E S E S E S E S
A) Mean Seizure 
duration
1) Prehospital 
treatment group (no)
1 8 8 5 4 7 2
• Out of hospital 9’30” 2’58” 5’28” 8’15” 6’55” 6’03” 2’
• In hospital 2’ 1’ 50” 1’08” 50” 1’33” 45”
• Total 11’30” 4’ 6’17” 9’23” 7’45” 7’36” 2’45”
2) Entire Study 
group (no)
14 17 42 8 11 16 5 - - 4 1
• Out of hospital 5’ 3’44” 4’28” 6’45” 3’59” 3’59” 1’38” 19’ 4’
• In hospital 1’14” 1’ 58” 1’25” 57” 1’49” 1’ 1’05” 30”
• Total 6’14” 4’28” 5’25” 7’02” 4’56” 5’48” 2’38” 13’45” 4’30”
B) Post total 
duration
8’31” 31’58” 3’19” 17’20” 26’03” 30’11” 2’08” 30’40” 24’
C) Seizure type
• GTCS -Primary 18 (58.06%) 32 (64%) 2 (7.41%) 4 (80%) 4 (100%) 1 (100%)
• GTCS-
Secondary
13 (41.93%) 16 (32%) 1 (20%)
• Myoclonic 2 (4%) 25 (92.59%)
S – Survived ; E-Expired ; ( ‘ ) – Hours ;(  “ ) – Minutes
The expired children had a prolonged postictal state when compared with the survivors, in all 
the etiological groups. Among the survivors, the children with Seizure disorder and Febrile SE were in 
the postictal state for a shorter period of 2 to 3 hours, whereas other cases had a postictal period 
lasting for many hours to days (Table 11). Drowsiness, tonic spasm of the limbs, abnormal pupillary 
reaction,  fever  and  vomiting  were  commonly  observed  during  the  postictal  period.  Two  seizure 
disorder children with focal onset  of  seizure developed hemiparesis on the side of  seizure onset, 
which recovered within 24 hrs.  
Myoclonic seizures were predominant in the Toxic encephalopathy group (92.59%) and this 
observation was statistically significant (p value = 0.0001). The generalized seizures especially the 
primary generalized seizures, were more in all other etiological groups (Table 11). 
One fourth of the seizure disorder children responded to Lorazepam.  Phenytoin was more 
effective to attain seizure control in Acute CNS infection (42%) and seizure disorder (34%), whereas 
Toxic encephalopathy required Phenobarbitone  in 33% of cases and Midazolam in 40.74% of cases. 
Thus the incidence of Refractory SE in highest among Toxic encephalopathy group and all such cases 
expired. 12% of seizure disorder children and 26% of CNS infections demanded Midazolam infusion 
due to Refractory status. Only 31.58% survived from Refractory SE. The maximum dose of Midazolam 
used in the study was 12 ug /kg/min for a child with Toxic encephalopathy, who finally succumbed 
(Table 6).
Complications  such  as  shock,  hypoglycemia,  elevated  levels  of  Blood  urea  and  Serum 
creatnine and high Serum creatine kinase levels were noted with statistical significance  in the expired 
children.  Acidosis  and hyperglycemia  were  more common among the survivors.  All  children  who 
required inotropic and ventilatory support expired. Seizure recurrence was equal among the survivors 
and  dead.  Five  children  developed  Aspiration  Pneumonia,  all  in  the  upper  region  of  Right  lung. 
Thrombophlebitis   occurred in four cases and five had ataxia, as a side effect of drug therapy. Three 
of the survivors had residual effect in the form of Hemiparesis and HIE  sequelae (Table 12).
Table 12: COMPLICATIONS IN CHILDREN WITH STATUS EPILEPTICUS
S.No. Complications Live (73) Dead (45) p Value
1. Shock 4 (5.48%) 8 (17.78%) 0.035
2. Blood sugar 
          High
          Low
24 (32.88%)
7 (9.59%)
6 (13.33%)
12 (26.67%)
0.031
0.0283
3. Urea 7 (9.59%) 22 (48.89%) 0.0001
4. Creatinine 1 (1.37%) 13 (28.89%) 0.0002
5. CPK 50 (68.49%) 45 (100%) 0.0001
6. Acidosis 43 (58.9%) 14 (31.11%) 0.006
7. Recurrent seizure 11 (15.07%) 13 (28.89%) 0.115
8. Thrombophlebitis - 4 0.0194
9. Pneumonia - 5 0.007
10. Inotropic support - 7 0.0008
11. Ventilatory support - 8 0.0003
12. Ataxia 
         Phenytoin
         Carbamazepine
4
1
-
-
0.1418
0.6186
13. Mean duration of 
hospitalization
8.36 days 2.89 days 
14. Sequelae 3 ( 4.1% )
Toxic encephalopathy had a higher incidence of shock (30%) either at presentation or during 
therapy. The same group had a greater need for inotropic support (18.52%) and ventilatory support 
(22.22%). Mechanical ventilation was also used in 6.45% of cases with Acute CNS infection. Seizure 
recurrence was more in Septicemic children (50%) followed by Seizure disorder (26%) and Acute CNS 
infection  (19.35%).  Mean  duration  of  hospital  stay  was  longest  among  survivors  of  Acute  CNS 
infection, mainly because of the need for prolonged antimicrobial therapy (Table 13) 
45% of Acute CNS Infection were Pyogenic meningitis and rest of them were them included 
Aseptic meningitis and Viral encephalitis.  Microbiological confirmation was passible only in 55% of 
pyogenic meningitis cases and 25% were due to Klebsiella species. Other organisms isolated from the 
CSF culture were Staphylococcus areus, Coagulase Negative Staphycococci, Escherichia coli  and 
Citrobacter species. 
In  children  with  seizure  disorder,  44%  were  asphyxiated  at  birth,  54%  had  delayed 
developmental milestones and 52% had Head circumference below the 5th percentile of Centre for 
Disease Control (CDC) charts21. Three fourth of the patients had seizures in the past and 30% had 
poor drug compliance. The developmental delay and poor drug compliance was more marked among 
the expired children. Among those children who underwent EEG and Comuputerised Tomographic 
(CT) scan of Brain, 97.67% and 44.19% had abnormal findings respectively (Table 14). One child, 
born  at  preterm,  had  fatures  of  arrested  hydrocephalus  due  to  old  intraventricular  hemorrhage 
(Table1). Interestingly, three children (6%) had recovered from SE in the past (Table14).
Table 13: ETIOLOGICAL DISTRIBUTION OF COMPLICATIONS
Complica- 
tions
Acute CNS 
infection 
(31)
Seizure disorder 
(50)
Toxic encepha-
lopathy
(27)
Febrile status 
epilepticus
(5)
Septicemia
(4)
Hypertensive 
S E T S E T S E T S E T S E T S
Shock at 
Presentation
1 3 4  2 1 3 1 4 5
Shock during
Therapy
1 1 3 3
Inotropic 
support
2 2 5 5
Ventilatory 
support
2 2 6 6
Recurrent 3 3 6 8 5 13 3 3 2 2
seizures
Mean duration 
of hospitali
zation (days)
15.78 1.48 6.45 4.07 5.88 3.68 6.75 1.33
Sequelae 2 2 1 1
                                                                                      S- Survived; E- Expired; T- Total
Table 14: SALIENT FEATURES OF CHILDREN WITH SEIZURE DISORDER
S.No. Seizure disorder Survived
(42)
Expired
(8)
Total
(50)
1. H/o birth asphyxia 19 
(45.24%)
3 
(37.5%)
22
(44%)
2. Delayed milestones 20 
(47.62%)
7
(87.5%)
27
(54%)
3. H.C. <5th pencentile 22 
(52.38%)
4
(50%)
26
(52%)
4. Family history positive 3 
(7.14%)
- 3
(6%)
5. Past H/o seizure 31 
(73.8%)
7
(87.5%)
38
(76%)
           Poor drug compliance 10 
(23.8%)
5 
(62.5%)
15
(30%)
           Good seizure control 3 
(7.14%)
- 3
(6%)
           Not on drugs 8 
(19.04%)
- 8
(16%)
6. Past H/o SE 3 
(7.14%)
- 3
(6%)
7. Abnormal EEG 41/42 
(97.62%)
1/1
(100%)
42/43
(97.67%)
8. Abnormal CT 19/43 
(44.19%)
- 19/43
(44.19%)
                                          H.C.- Head Circumference
About 5 ml of Neem Oil ingestion lead to seizures after an average time interval of 1 hr 42 min. 
In most of the cases, it was administered as a native remedy for respiratory infections. Ironically, two 
children received neem oil for seizure control and thus end up with SE. All children had Myoclonic 
seizures. The average seizure duration was 5 hr 21 min and 48% of cases progressed to Refractory 
stage inspite of therapy. The neem oil encephalopathy has a very high mortality rate of 64 per 100 
children (Table15).
 
Table 15: SALIENT FEATURES OF CHILDREN WITH NEEM OIL ENCEPHALOPATHY
S.No. Variables Survived Expired Meal value
1. Amount consumed 5.2ml 5.46ml 5.38ml
2. Indication
         URI 5 5 10 (40%)
        AGE - 3 3 (12%)
        Deworming 2 7 9 (36%)
        Accidental - 1 1 (4%)
3. Time interval between 
consumption
1hr 42min 1hr 42min 1hr 42min
4. % of Refractory status 22.22% 62.5% 48%
5. Total seizure duration 4hrs 45min 5hrs 36min 5hr 21min
6. Specific mortality rate - - 64 per 100
The critical analysis of the study reveals the following factors to be associate with high risk for 
mortality in children with Status Epilepticus.
1. children less then 1 year of age carried a statistically significant risk for death (p value = 0.0343) 
when compared with other age group.
2. 95% of the deaths have occurred in children with total seizure duration exceeding 1 hr. When the 
seizures have not responded to more than 45 min of treatment in the hospital, then the risk for 
mortality becomes statistically significant (p value = 0.0129) (Table 16). 
Table 16: Inhospital Seizure duration and risk of mortality
Inhospital Seizure duration Survived Expired
<45 min 36 11
>45min 37 34
p value = 0.0129 (significant)
3. Acute CNS infection and Toxic encephalopathy were significantly associated with higher incidence 
of death, compared to Seizure disorder and Febrile SE. All children with Septicemia have expired.
4. Presence of shock at the time of presentation (p value = 0.035) and the need for Inotropic support 
(p value = 0.0008) and ventilatory support 
(p value = 0.0003) during therapy significantly raised the chances for death. 
5. Development of complications such as raised blood urea level (p value = 0.0001), elevated serum 
creatinine level (p value = 0.0002),  hypoglycemia (p value = 0.0283), pneumonia (p value = 0.007) 
and thrombophlepitis (p value = 0.0194) were observed more significantly in the expired group.
        Discussion
DISCUSSION
The present  study was  compared with  many other  studies  done in  and out  of  India  over 
different periods of time. This comparative analysis throwed light on various aspects of the disease 
such as epidemiological  trend,  causative factors  and effectiveness  of  therapeutic  interventions,  in 
various parts of the world. There is not much of published data either population based or hospital 
based studies from the Indian subcontinent22.
A study with similar objectives was carried out by Gulati et al at All India Institute of Medical 
Sciences (AIIMS), New Delhi. However it was a restrospective study and included only the children 
between  1 month and 10 years of age22.
56% of patients in AIIMS study were below 5 years of age22. In our observation, three fourth of 
all our children were younger than 4 years of age. The reason for this predominance of SE in younger 
children  is  not  known.  Probably,  mechanism for  control  of  seizure  activity  are  fragile  in  younger 
children and may get disrupted with minimal abnormalities in neurofunction22. Similarly Kroczka et al 
from Cracow reports that SE appeared more frequently in children diagnosed with epilepsy during the 
first 2 years of life23.        
Males  were  dominant  in  the  Gulati  et  al  study  (male  :  female  =  2.75:1)  but  the  gender 
difference in our study was minimal (male : female = 1.36:1). Gulati et al have observed that fever, 
upper respiratory infection and gastroenteritis precedes many SE cases22. This was also noted in the 
present study. Oliviera et al from Portugal has identified fever as the inducing factor for SE in 27% of 
the cases24.
About 60% of cases in the AIIMS study have received some treatment before reaching their 
emergency  service  and  the  combination  of  Diazepam  and  Phenytoin  was  the  most  commonly 
administered drug for the initial control of seizures22. In our institution, 30% of cases have received 
some treatment prior hospitalization and 75% of the prehospital treatment group have received IM 
injections  and the most  common therapy was IM Diazepam, in  whom the treatment  details  were 
available.
The most common seizure type observed in the AIIMS study was GTCS (63.3%)22, which is 
similar to the present study (77.11%). Myoclonic seizures have contributed to 22.88% our cases, as 
against 6.6% of AIIMS cases22. This could be due to the higher incidence of Myoclonic seizures in 
association with Neem oil encephalopathy, an etilology unique to our region.
One third of  the cases in Gulati  et  al  study required more than three drugs to control  the 
seizures22, whereas 22% of our cases have not responded to the first three drugs. The incidence of 
Refractory SE (RSE) in the AIIMS study was higher (40%)22, when compared with our study (22%) 
Prasad et  al  from Canada comments that  longer a seizure lasts,  the more difficult  it  becomes to 
control and that seizures can have immediate and long term adverse consequences on immature and 
developing brain25. 
All the RSE in our study were managed with Midazolam infusion and 68.42% of such children 
expired,  yielding  a  morality  rate  of  68.42%  for  RSE.  However  meta-analysis  by  Gilbert  et  al  of 
Refractory status eplepticus reveals that there were no deaths among children treated with Midazolam 
and the overall morality rate for RSE was 16%26. 
The etiology of seizures is usually analysed because this has been shown to affect the morality 
of SE and can affect the duration of seizures26. Epilepsy, followed by acute symptomatic seizures were 
the common causes identified in AIIMS study22. Whereas the reverse was true in the present study, 
with acute CNS infection and Toxic encephalopathy dominating the symptomatic group. Oliviera et al 
has made an observation similar to ours with 53% of their cases being symptomatic seizures24.
34% of our cases (Seizure disorder – 38; Seizure disorder with Neem oil encephalopathy – 2) 
and 47% (14/30) of AIIMS cases22 had seizures in the past. This sharply contradicts with the study by 
Sagduyu et al, Turkey27, whose 72% of SE cases had pre existing Seizure disorder. Status Epilepticus 
was the first manifestation of Seizure disorder in 24% of our cases. But Lauterbach et al from Cracow, 
reports a higher figure with 54% of their children with epilepsy manifesting first with a status28. One 
third  of  our  Seizure  disorder  cases  had  poor  drug  compliance.  Sagduyu  et  al  also  reports  that 
antiepileptic drug withdrawal is the most prominent cause for SE27. But Kroczka et al strongly says that 
discontinuation of treatment was not a reason of SE in any of their cases23.
30 of our cases (25.42%) had developmental delay (Seizure disorder with developmental delay 
– 27, cerebral palsy with acute CNS infection – 1, cerebral palsy with Neem oil encephalopathy – 1, 
Downs syndrome with acute CNS infection – 1). A similar incidence (26.67%) was recorded in the 
AIIMS study22. Lauterbach et al opines that the probable risk factor for SE was the association with 
mental retardation28.
The overall mortality rate in AIIMS study was 30%22 as against 38% in our study. The Neem oil 
encephalopathy, unique to our area may be responsible for this slightly higher mortality, because it 
accounted for one fifth of the total cases but to one third of death. With the exclusion of Neem oil 
encephalopathy(total-93; death-29), our study population mortality rate of 31%  correlates well with the 
AIIMS study. 
Margosa  oil  (Neem  Oil)  is  a  long  chain  fatty  aid,  extracted  from  the  seeds  of  Neem29 
(Azadirachta indica)30 and has been shown to cause a Reye-like syndrome with death from hepato 
encephalopathy31.  The oil  is  widely used as a traditional  medicine by Indians in  India,  Sri  Lanka, 
Burma, Thailand, Malaysia and Indonesia and it causes toxic encephalopathy particularly in infants 
and young children, with recurrent generalized seizures, leucocytosis and metabolic acidosis29. There 
toxic effects might be due to presence of Aflatoxin and other toxic compounds  in neem oil. The oil 
acts  rapidly  within  30  min,  on  the  nuclei  of  the  hepatocytes31,  uncouples  mitochondrial  oxidative 
phosphorylation, thus inhibiting the respiratory chain30 .
Sagduyu et al reports a lower case fatality rate of 21%27. However the mortality rate reported in 
American text books is around 5%1. Meta analysis by Gilbert et al states that outcomes in India could 
be different for non drug related or etiology related reasons. For example, slow transportation to the 
site of medical care could both increase mortality and decrease efficacy. Differences in intensive care 
unit practices also could alter mortality26. Kroczka et al adds that the low frequency of SE in their study 
can be related to continuous access to pediatric neurologist and experienced nurse team23  .
More deaths have occurred in younger children, below 3 years in AIIMS study22 and below 4 
years in our study. Males had higher mortality rate in AIIMS study22 ,whereas there was no significant 
gender difference with mortality in our study.
The major determinants of fatal outcome identified by Sagduyu et al were27
1. increasing age 
2. longer duration of SE before initiating therapy
3. CNS infection as a cause for SE
These factors correlate well with our study.
Following is the comparison of risk factors for death following SE, identified  in our study and 
AIIMS study22
S.No Risk factors AIIMS study Our Study
1 Age <36 months <1year*
2 Total seizure duration >45 min* > 1 hour
3 Response to treatment > 1 hour > 45 min*
4 Shock Present* Present*
5 Other complications Need for inotropic 
              support* 
Need for ventilatory    
               support*
Elevated  blood  urea  & 
serum creatinine* 
Hyperglycemia*
Pneumonia*
Thrombophlebitis*
6 Etiology Acute CNS infection* 
Toxic encephalopathy* 
* - Statistically significant
Limitations 
Of 
The Study
LIMITATIONS
1. Children with head injury were not included in the study as these cases were not managed in our 
department.
2. Toxicological studies in children with toxic encephalopathy could not be done due to practical 
difficulties.
3. Antiepileptic drug level estimation could not be done due to lack of facility in our region.
4. Laboratory estimation of serum Sodium, Potassium and Magnesium were not available in our 
institution during the study period. Serum calcium level analysis was not available regularly on all 
days. As such these biochemical parameters could not be included in the study.
5. Our hospital does not have the provisions for urine myoglobin analysis.
6. Microbiological confirmation of CNS infection was not possible in majority of the cases due to 
technical difficulties in our set up.
7. Ventilatory therapy could not be guided by Arterial blood gas analysis due to lack of facility.
8. EEG could not be done in all cases and EEG monitoring of therapy of Refractory SE was not 
done due to limited resources and lack of bedside EEG monitor.
9. CT brain was not done in all children either due to the financial constraints of the parents or due 
to the poor general condition of the patient, preventing transport to the CT-Scan room.
10. The long term follow up could not be done due to the poor turn up of the cases for review. 
Conclusion
CONCLUSIONS
1. Status Epilepticus is common pediatric neurological emergency with life threatening potential.
2. Children below 4 years of age and especially the infants were most commonly affected by Status 
Epilepticus.
3. Toxic encephalopathy and Acute CNS infection were the common etiology in infants, whereas 
seizure disorder was more prevalent in older children.
4. Toxic encephalopathy due to neem oil ingestion, as a cause for SE is unique to our Madurai 
region. It is common in children below 2 years and carries a high mortality rate.
5. Many children with acute CNS infection and febrile SE had a preceding febrile illness.
6. One fourth of children diagnosed as seizure disorder, had SE as the first manifestation of their 
disorder.
7. Among  known  seizure  disorder  children  on  antiepileptic  therapy,  one  third  had  poor  drug 
compliance and presented with SE.
8. Intramuscular route was the most preferred method of drug administration among the physicians, 
who subsequently referred the cases to our institution.
9. Longer  the  seizure  duration,  lesser  the  chance  for  early  termination  with  drug  therapy and 
greater the risk for death.
10. Prolonged postictal state was mainly observed among children with toxic encephalopathy and 
acute CNS infection.
11. Presence of shock, respiratory depression, aspiration pneumonia and renal failure significantly 
increases the risk for death.
12. Toxic encephalopathy and Acute CNS infections have a higher mortality rate and were the major 
contributors in expired group. 
 Recommendations
RECOMMENDATIONS
1. Parents of Seizure Disorder children are to be educated about the need for strict     drug 
compliance and the significance of early hospital visit, if the seizures go    uncontrolled for 
more than few minutes.
2. In children with poor seizure control inspite of good drug compliance, training      the 
parents to administer Rectal Diazepam at home, in the prescribed dose can     be considered.
3. There is an urgent need for public awareness campaign in this region, about the      harmful 
effects of Neem oil administration to the children.
4. The Intramuscular Midazolam may be preferred for the emergency management of Status 
Epilepticus by the physicians in office set up, as there is  a difficulty in establishing an 
intravenous access in a convulsing child and rectal administration of Diazepam may not be 
socially acceptable.
5. The  supportive  facilities  for  the  management  of  Status  Epilepticus  such  as  Vital  signs 
monitors, appropriate biochemical investigations and electrophysiological studies (Bedside 
EEG) needs further improvement.
6. The early recognition and intensive management of shock and respiratory     depression may 
improve the survival of children with Refractory Status      Epilepticus.
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Protocol
MANAGEMENT PROTOCOL FOR GENERALISED CONVULSIVE STATUS 
EPILEPTICUS
Airway:
Open Airway (Head tilt & Chin lift)
Jaw thrust & Cervical spine stabilization, if trauma is suspected.
Oropharyngeal suction, NG tube decompression, insert airway adjunct.
Breathing:
Spontaneous breathing: O2 through mask – 10Lit / min.
Apneic: Bag & Mask ventilation with O2 – 10 Lit / min.
Circulation:
I.V. Access (if possible 2 I.V lines)
Collect blood samples for glucose, urea, creatinine, electrolyte &
calcium
Correct shock, if present, with NS 20ml / Kg bolus
Administer I.V. bolus of Dextrose (2ml / kg of 25% D (or) 5ml/kg 10% D)
Record body temperature & BP
(Please note the time of starting each Antiepileptic drug & time when 
obvious seizures ceases)
0 min: Inj.Lorazepam (I dose) 0.1mg/kg I.V., @ 2mg/min, Max.4mg/dose
10 min: Inj.Lorazepam (II dose), same dosage
20 min: Inj. Phenytoin (I dose) – 20mg/kg I.V. Max. dose 100mg, @ 
                  1mg/kg/min, Max. rate 50mg/min
Total dose to be diluted in 10ml of NS & infused @ 0.5ml/min
Monitor HR, BP & Perfusion
40 min: Inj.Phenytoin (II dose) 10mg/kg I.V., @ 1mg/kg/min
60 min: Inj. Phenobarbitone (I dose) 20mg/kg I.V., @ 2mg/kg/min
      Total dose to be diluted in 10ml & infused @ 1ml / min
Intubate the child electively & Provide Assisted ventilation
REFRACTORY STATUS EPILEPTICUS
Inj.Midazolam
0.2mg / kg I.V. bolus followed by continuous
I.V. infusion @ 1 μg / kg / min, increasing by
1 μg / kg / min every 15 min till a maximum
of 18 μg / kg min or seizure control. The optimum
rate of seizure control is maintained for a period of
12 hrs. Subsequently the infusion rate is gradually 
decreased by 1 μg / kg / min every 2 hrs and then
weaned off.
(Midazolam infusion preparation 
6mg in 100ml of 5% D 
        Body wt in kg = No. of microdrops / min
     deliver 1 μg / kg / min)
Closely monitor Haemodynamic status – HR, BP, CRT & Urine output.
                          Inotropic support may be needed.
Inj. Dopamine infusion - Start with 10 μg / kg / min & can be increased upto 20 μg/kg/min
(Dopamine Infusion Preparation:
        6 x body wt. (kg) = mg of Dopamine added to NS to make total volume of 100ml
1ml / hr          deliver 1 μg / kg / min)
Seizure not controlled with maximum dose of Midazolam
BARBITURATE COMA
Inj. Thiopentone
4mg / kg loading dose over 2 min followed by
continuous I.V. infusion @ 0.2mg / kg / min, 
increasing by 0.1 mg / kg / min every 5 minutes
till the seizures are controlled or a maximum dose
of 10mg / kg / min. Barbiturate coma is maintained
for 12 hrs of Seizure control &  then weaned off.
(Thiopentone Infusion Preparation
300 mg in 50ml of 5% D
Body wt. in Kg = No. of microdrops / min
     deliver 0.1mg / kg / min)
General Anaesthesia with Halothane or Isoflurane.
Proforma
STATUS EPILEPTICUS - CLINICAL PROFILE AND MANAGEMENT 
PROFORMA
Name : Address: 
Age :
Sex :
Hospital No. :
Date of Admission :
Date of Discharge/ : Informant:
Death
Unit : Reliability:
Time of Admission  :
Reason for Admission : Convulson / Postictal / Others
HISTORY OF PRESENT ILLNESS : 
Seizures : Time & Date of Onset    :
     
         Type    :  generalized / focal / focal with secondary generalization
          Pattern    :  Tonic / Clonic / Tonic-clonic / myoclonic / subtle
     Periodicity    :  Continuous / Intermittent
                          Associated features    :    sphincter incontinence
                       frothing from mouth
      vomiting
      injuries
                   cyanosis 
TRIGGERING FACTORS :
Fever  - duration      :
  Nature         :
AED compliance      :
Others            :
    Treatment given outside, if any     :
ASSOCIATED SYMPTOMS :
Head ache
Visual disturbances
Vomiting
Head injury
Respiratory infection : URI / LRI / Pneumonia
GIT infection : diarrhea / dysentery
Renal : dysuria / oliguria / hematuria
Skin lesions :  
                                          Drugs / Toxins :
PAST HISTORY :
H/O seizures :
Age of onset :
Clinical type :
Evaluation details : EEG
    Imaging study
                    Neurologists Opinion :  
                          Current treatment : 
Drug Compliance : good / poor
Seizure control : good / poor
Last episode of seizure : 
Status epilepticus,if any : 
H/O exanthematous illness
H/O drug intake(other than AEDs)
H/O drug reactions or allergies, if any
H/O pica 
H/O contact with TB
H/O hospitalisation
ANTENATAL HISTORY :
BIRTH HISTORY:
Mode of  Delivery
Birth asphyxia
Birth weight
Term / Preterm
NEONATAL HISTORY:
Seizures 
Jaundice
Letharginess / feeding difficulty / vomiting
Hospitalisation, if any :
DEVELOPMENTAL MILESTONES:
Normal / Delayed / Regression
IMMUNISATION HISTORY:
Appropriate for age / missed :
Date of last Vaccination :
Additional vaccines, if any :   HIB / HB / Chicken Box / ARV
FAMILY HISTORY:     
Consanguinous / Non Consanguinous parents
Health & Development of siblings
Seizures 
Neurological disorder
Pedigree Chart
SOCIO ECONOMIC STATUS:
Modified Kuppusamy’s scale
EXAMINATION: 
Level of Consciousness : comatose / stuporous / drowsy / convulsing
Description of convulsion:  
Generalised : tonic-clonic / tonic / clonic / myoclonic
Subtle : Muscle twitching - Face
  Limbs
    Trunk
   Tonic eye deviation
   Nystagmus
Respiration : rapid / shallow / apnea
: regular / irregular
  : Cyanosis
Peripheries : warm / cold
Peripheral pulses : bounding / normal / feeble
            Injuries : 
Hydration : fair / dehydrated
Dysmorphology : 
Vital Signs:      Anthropometry   
                  
RR - Weight - 
PR - Length - 
Temp - HC- 
  
BP - CC-
CRT - AF -  
TREATMENT
Time Seizure Drugs
Total duration of seizures :
POSTICTAL STATE :
        
                          Duration of drowsiness :
  Neurological deficit        : 
            Vomiting   :
 Automatic behaviour      :
Fever       :
      Head ache       :
Myalgia   :
Urine output      : adequate / reduced 
Urine Colour      : clear / yellow / red
CENTRAL NERVOUS SYSTEM :
1. Higher Functions : Conscious / drowsy / stuporous / comatose
2. Cranial Nerves :
 II :  Pupils
:  Fundi
III, IV & VI :  EOM
VII : 
Others :
3.Motor System  :                  Right Left
Bulk  - UL
 - LL
Tone - UL
 - LL
          Power - UL
          - LL
Involutary Movements : 
4.Sensory System :
5.Reflexes : 
a) Superficial
                Corneal 
     Conjunctival
     Abdominal -   upper 
  lower
     Cremasteric 
     Plantar
           b) DTR
      Upper Limb
      Lower Limb
c) Primitive Reflexes :
  
6.  Cerebellar Signs :
7.  Spine and Cranium 
8.  AF - Normal / Tense
9.  Meningeal Signs
RESPIRATORY SYSTEM :
B/L air entry
Breath sounds 
Added sounds
CARDIO VASCULAR SYSTEM :
Apical impulse
Heart sounds
Added sounds
Murmur
ABDOMEN :
Liver 
Spleen
Any other mass :
Bowel sounds 
CLINICAL DIAGNOSIS :
 
INVESTIGATIONS
1. Blood - Sugar
- Urea
- Creatinine
- Bicarbonate
2. Sr.CPK
3.   EEG
4.   Imaging Studies (CT brain)
5.   Others
Additional Treatment:
Maintenance AED therapy:
Other Drugs:
COMPLICATIONS:   
1. Recurrent seizure
2. Drug adverse effect
3. Others
OUTCOME :
Discharge   : Neurological status
         Maintainence AED
Death        : Cause of death.
FINAL DIAGNOSIS:
COMMENTS:
Master Chart
MASTER CHART
AGE AND GENDER WISE DISTRIBUTION OF CASES IN EACH ETIOLOGICAL
GROUP
Etiology & Age 
group
Survived Expired Grand 
Total
Male Female Total Male Female Total
1. Acute CNS 
infection
1 mon – 1yr 2 3 5 1 5 6 11
1 – 2 yrs 3 - 3 3 - 3 6
2 – 3 yrs 2 2 4 - 3 3 7
3 – 4 yrs - - - - - - 0
4 – 8 yrs 1 - 1 1 4 5 6
8 – 12 yrs - 1 1 - - - 1
Total 8 6 14 5 12 17 31
2. Seizure 
disorder
1 mon – 1 yr 3 5 8 - 1 1 9
1 – 2 yrs 5 3 8 - - 0 8
2 – 3 yrs - 4 4 1 2 3 7
3 - 4 yrs 4 3 7 - - - 7
4 – 8 yrs 8 4 12 3 1 4 16
8 – 12 yrs 3 - 3 - - - 3
Total 23 19 42 4 4 8 50
3. Toxic 
encephalopathy
1 mon – 1 yr 5 1 6 7 3 10 16
1 – 2 yrs 2 1 3 4 - 4 7
2 – 3 yrs - - - - 1 1 1
3 - 4 yrs - 1 1 1 - 1 2
4 – 8 yrs 1 - 1 - - - 1
8 – 12 yrs - - - - - - -
Total 8 3 11 12 4 16 27
4. Febrile status 
epilepticus
1 mon – 1 yr 2 - 2 2
1 – 2 yrs 1 1 2 2
2 -3 yrs - - - -
3 – 4 yrs - - - -
4 – 8 yrs 1 - 1 1
Total 4 1 5 5
5. Septicemia 
1 mon – 1 yr 3 1 4 4
6. Hypertensive 
encephalopathy
(12 yr) 1 - 1 1
List 
Of 
Abbreviations 
Used
LIST OF ABBREVIATIONS
1. CNS - Central Nervous System 
2. ECG - Electrocardiogram 
3. EEG - Electroencephalogram 
4. GCSE - Generalized Convulsive Status Epilepticus 
5. GTCS - Generalized Tonic Clonic Seizures 
6. HIE -  Hypoxic Ischemic Encephalopathy 
7. hr -  Hour
8. ILAE - International League Against Epilepsy 
9. I.M - Intra Muscular  
10. I.O -  Intra Osseous 
11. I.V -  Intra Venous
12. kg - Kilogram 
13. mg - Milligram 
14. min -  Minute 
15. ml - Milliliters
16. NCSE - Non Convulsive Status Epilepticus
17. NMDA - N-Methyl d-Aspartate
18. RSE - Refractory Status Epilepticus 
19. SE - Status Epilepticus 
20. yrs - Years 
 
 
